Literature DB >> 7116736

beta-blocker plasma concentrations and inflammatory disease: clinical implications.

R E Schneider, H Bishop.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7116736     DOI： 10.2165/00003088-198207040-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  23 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Serum lipids and glycoproteins in acute myocardial infarction.

Authors:  S Snyder; B C Durham; A S Iskandrian; E L Coodley; J W Linhart
Journal:  Am Heart J       Date:  1975-11       Impact factor: 4.749

3.  Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease.

Authors:  R E Schneider; J Babb; H Bishop; M Mitchard; A M Hoare
Journal:  Br Med J       Date:  1976-10-02

Review 4.  Individualization of propranolol therapy.

Authors:  D G Shand
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

5.  Increased plasma binding of quinidine after surgery: a preliminary report.

Authors:  D Fremstad; K Bergerud; J F Haffner; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

Review 6.  Impaired drug metabolism in rats with adjuvant-induced arthritis: a brief review.

Authors:  M W Whitehouse; F J Beck
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

7.  Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.

Authors:  G Sager; V Hansteen; I Aakesson; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

8.  Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

Authors:  M Wood; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

9.  Influence of surgery on plasma propranolol levels and protein binding.

Authors:  J Feely; A Forrest; A Gunn; W Hamilton; I Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

10.  Propranolol in the control of blood pressure: a dose-response study.

Authors:  M J Serlin; M L Orme; N S Baber; R G Sibeon; E Laws; A Breckenridge
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875
View more
  7 in total

Review 1.  Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.

Authors:  J G Riddell; D W Harron; R G Shanks
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

2.  Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.

Authors:  F Keller; M Maiga; H H Neumayer; H Lode; A Distler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

3.  Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart.

Authors:  Saeed Sattari; William F Dryden; Lise A Eliot; Fakhreddin Jamali
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 4.  First-pass elimination. Basic concepts and clinical consequences.

Authors:  S M Pond; T N Tozer
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

5.  Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats.

Authors:  J Emami; F M Pasutto; F Jamali
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

Review 6.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

7.  Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.

Authors:  F M Belpaire; M G Bogaert; P Mugabo; M T Rosseel
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.